Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,796,837
+$67,424 QoQ
Shares Held
7,075
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#2,446
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canton Hathaway, LLC holds $4,383,166 across 9 Drug Manufacturers - General names. JNJ ranks #1 (41.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
7,075 | $1,796,837 | |
| 2 | LLY |
ELI LILLY & Co
|
873 | $1,047,102 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,898 | $757,893 | |
| 4 | ABBV |
AbbVie Inc.
|
1,326 | $333,674 | |
| 5 | AMGN |
Amgen Inc
|
515 | $186,491 | |
| 6 | PFE |
Pfizer Inc
|
4,654 | $112,068 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,445 | $83,260 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
345 | $43,587 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,796,837 | 7,075 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,729,413 | 7,075 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,464,171 | 7,075 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,314,256 | 7,088 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,082,692 | 7,088 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,173,318 | 7,075 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $832,577 | 5,757 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $965,391 | 5,957 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $870,675 | 5,957 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,513,403 | 9,567 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,499,531 | 9,567 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,520,898 | 9,765 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,788,112 | 10,803 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $1,860,465 | 12,003 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,120,329 | 12,003 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $2,165,010 | 13,253 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,407,568 | 13,563 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,403,770 | 13,563 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $2,320,222 | 13,563 | Shares | Sole | 2022-01-06 | |
| 2021-09-30 | $2,246,949 | 13,913 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,150,351 | 13,053 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $2,107,788 | 12,825 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,513,208 | 9,615 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,322,649 | 8,884 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,067,944 | 7,594 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $969,575 | 7,394 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||